| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $591.0M | +28.9% |
| Cost of Revenue | $215.5M | +23.3% |
| R&D Expense | $69.5M | +7.7% |
| SG&A Expense | $213.6M | +12.7% |
| Operating Income | -$259.0M | -4.3% |
| Interest Expense | $7.3M | +3.8% |
| Pre-tax Income | -$280.7M | -12.2% |
| Income Tax | -$1.5M | -149.3% |
| Net Income | -$279.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.1M | +16.6% |
| Accounts Receivable | $106.3M | +27.2% |
| Current Assets | $236.4M | +20.6% |
| Total Assets | $466.5M | +17.4% |
| Current Liabilities | $128.7M | +21.7% |
| Long-term Debt | $184.0M | +0.2% |
| Total Liabilities | $338.5M | +10.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $78.5M | +77.2% |
| Capital Expenditures | $22.2M | +134.5% |
| Investing Cash Flow | -$48.4M | -3.4% |
| Financing Cash Flow | -$12.6M | -122.7% |
| Free Cash Flow | $56.3M | +61.6% |
| -11.9% |
| EPS (Basic) | -$2.01 | +31.9% |
| EPS (Diluted) | -$2.01 | +31.9% |
| Stockholders' Equity |
| $128.0M |
| +41.5% |